Cardiovascular mortality in women with rheumatoid arthritis. 1995

R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
Rheumatism Foundation Hospital, Heinola, Finland.

OBJECTIVE To investigate the relationship of deaths from cardiovascular causes in mortality of women with rheumatoid arthritis (RA). There is increasing evidence that subjects with RA have increased mortality from cardiovascular causes, but little is known of its determinants. METHODS Our study included all women subjects in Finland who died during 1989 and who were entitled to reimbursement for medication for RA under the national health insurance plan. Demographic data on the Finnish population and health insurance statistics were used for computations. RESULTS Half of the 1186 deaths of women were due to cardiovascular causes. The distribution of specific diagnoses within this disease group did not differ appreciably from that in the female population as a whole. However, there was a 34% excess of deaths due to cardiovascular causes. The median age at death in women with RA was 2.5 years lower than that in the whole population with deaths due to cardiovascular causes. CONCLUSIONS Deaths due to cardiovascular causes constitute and important determinant in the surplus of mortality associated with RA in women.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009026 Mortality All deaths reported in a given population. CFR Case Fatality Rate,Crude Death Rate,Crude Mortality Rate,Death Rate,Age Specific Death Rate,Age-Specific Death Rate,Case Fatality Rate,Decline, Mortality,Determinants, Mortality,Differential Mortality,Excess Mortality,Mortality Decline,Mortality Determinants,Mortality Rate,Mortality, Differential,Mortality, Excess,Age-Specific Death Rates,Case Fatality Rates,Crude Death Rates,Crude Mortality Rates,Death Rate, Age-Specific,Death Rate, Crude,Death Rates,Determinant, Mortality,Differential Mortalities,Excess Mortalities,Mortalities,Mortality Declines,Mortality Determinant,Mortality Rate, Crude,Mortality Rates,Rate, Age-Specific Death,Rate, Case Fatality,Rate, Crude Death,Rate, Crude Mortality,Rate, Death,Rate, Mortality,Rates, Case Fatality
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
March 2003, Circulation,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
January 1989, Cardiology,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
October 2008, The American journal of medicine,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
January 2024, Kardiologiia,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
January 2011, Ugeskrift for laeger,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
November 2004, Arthritis and rheumatism,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
November 2002, Annals of the rheumatic diseases,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
March 1997, The Journal of rheumatology,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
October 2023, Seminars in arthritis and rheumatism,
R Myllykangas-Luosujärvi, and K Aho, and H Kautiainen, and H Isomäki
April 2024, Seminars in arthritis and rheumatism,
Copied contents to your clipboard!